Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for August 29th, 2011

« Older Entries

Slinky Sue launches fitness club

By on Monday, August 29th, 2011 | No Comments

… of honour will be Alex Strong, who suffers from a rare form of childhood leukaemia, and the event will raise funds for PACT (Parents Association of Children with …

Read More...

Breakthrough research isolates human blood stem cell in its purest form

By on Monday, August 29th, 2011 | No Comments

… Dick, who pioneered the field of cancer stem cells with previous discoveries in human leukemia and colon cancer, also developed a way to replicate the entire human leukemia disease …

Read More...

Talon Therapeutics Receives Special Protocol Assessment Agreement from the Food and Drug Administrat

By on Monday, August 29th, 2011 | No Comments

… Administration for Its Phase 3 Confirmatory Study of Marqibo(R) in Newly Diagnosed Acute Lymphoblastic LeukemiaTalon Therapeutics Receives Special Protocol Assessment Agreement from the Food and Drug Administration for Its …

Read More...

Talon Therapeutics Receives Special Protocol Assessment Agreement from the Food and Drug Administration for Its Phase 3 Confirmatory Study of Marqibo(R) in Newly Diagnosed Acute Lymphoblastic Leukemia

By on Monday, August 29th, 2011 | No Comments

… sulfate liposomes injection) in adults with newly diagnosed Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). Talon submitted a new drug application (NDA) to the FDA in July 2011 …

Read More...

Daughter’s cancer diagnosis spurs Santa Rosa man to help other patients

By on Monday, August 29th, 2011 | No Comments

… Suzanne, experienced the same emotions when their daughter, Kyra, was diagnosed with acute lymphoblastic leukemia. She was not yet 2 at the time. “It comes completely out of the …

Read More...

Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)

By on Monday, August 29th, 2011 | No Comments

Condition :   Leukemia Interventions :   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Ponatinib;   Drug: G-CSF (Filgrastim);   Drug: Rituximab;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Solu-medrol ( Methyl Prednisolone);   Drug: Citrovorum (Leucovorin);   Drug: Prednisone;   Drug: Pegfilgrastim (Neulasta) Sponsors :   M.D. Anderson Cancer Center;   Ariad Pharmaceuticals Not yet recruiting – verified August 2011

Read More...

Web-based Education on Oral Cancer for Primary Care Physicians in Ohio

By on Monday, August 29th, 2011 | No Comments

Condition :   Oral Cancer Intervention :   Other: Web-based Educational Intervention Sponsors :   Creighton University;   National Institute of Dental and Craniofacial Research (NIDCR) Enrolling by invitation – verified August 2011

Read More...

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

By on Monday, August 29th, 2011 | No Comments

Conditions :   Pain;   Advanced Cancer Interventions :   Drug: Sativex®;   Drug: Placebo (product code GA0034) Sponsors :   GW Pharmaceuticals Ltd.;   Otsuka Pharmaceutical Development & Commercialization, Inc. Not yet recruiting – verified August 2011

Read More...

CRRS-4 Pivotal Somo•v™ ABUS ROC Reader Observer Study

By on Monday, August 29th, 2011 | No Comments

Condition :   Breast Cancer Intervention :   Device: Automated Breast Ultrasound (ABUS) Sponsor :   U-Systems, Inc. Enrolling by invitation – verified August 2011

Read More...

Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

By on Monday, August 29th, 2011 | No Comments

Conditions :   Medullary Thyroid Carcinoma;   Multiple Endocrine Neoplasia Type 2 Intervention :   Sponsor :   National Cancer Institute (NCI) Recruiting – verified May 2011

Read More...
« Older Entries